Also, how long before this TRXC/Alf gets the stock up to $14 which was the high for the stock? TRXC still trading at all time lows, obviously Surgibot is DOA (otherwise you don't purchase an entirely new platform). Lot of dead money in TRXC with more dilution on the way. They also forbid any sell of the stock for 1 and 2 year which sheds light that TRXC is a long way from becoming profitable, will probably need to get to $20/share for many people to make money on this product.
FDA approval for ALF is minimum 3 years away and surgibot will never make it to make and if it does, hospitals will have to buy 2 systems and take up twice the space if they buy ALF and Surgibot - cost prohibitive and will gain no traction.
Good thing TITXF will be a single port and multi-port in one surgical robotic system.
TRXC was once $14/share now trading at $2.60/share and appears to be heading down with this acquisition since neither of these products are FDA approved. Go check out how much revenue ALF has since they got CE mark 10 years ago.
News 
Market Data 
Discover 
